Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody

Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody

US Patent 12291571 · Granted May 6, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating atopic dermatitis by administering an IL-4R antagonist2025
Compositions monovalent for CD28 binding and methods of use2024
Methods for treating or preventing asthma by administering an IL-4R antagonist2023
Methods for treating skin infection by administering an IL-4R antagonist2023
Methods for treating allergy and enhancing allergen-specific immunotherapy by ad2022
Methods of treating eosinophilic esophagitis by administering an antibody which 2022
Methods of treating eosinophilic esophagitis by administering an antibody which 2022
Methods of treating eosinophilic esophagitis by administering an antibody which 2022
Methods of treating eosinophilic esophagitis by administering an antibody which 2022
Methods of treating eosinophilic esophagitis by administering an antibody which 2022
Method of treating an allergy with allergen-specific monoclonal antibodies2022
Method of treating an allergy with allergen-specific monoclonal antibodies2022